4.2 Article

Global variation in CYP2C8-CYP2C9 functional haplotypes

Journal

PHARMACOGENOMICS JOURNAL
Volume 9, Issue 4, Pages 283-290

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/tpj.2009.10

Keywords

CYP2C8; CYP2C9; paclitaxel; population genetics; haplotypes; evolution

Funding

  1. NIH [AA009379, GM57672]

Ask authors/readers for more resources

We have studied the global frequency distributions of 10 single nucleotide polymorphisms (SNPs) across 132 kb of CYP2C8 and CYP2C9 in similar to 2500 individuals representing 45 populations. Five of the SNPs were in noncoding sequences; the other five involved the more common missense variants (four in CYP2C8, one in CYP2C9) that change amino acids in the gene products. One haplotype containing two CYP2C8 coding variants and one CYP2C9 coding variant reaches an average frequency of 10% in Europe; a set of haplotypes with a different CYP2C8 coding variant reaches 17% in Africa. In both cases these haplotypes are found in other regions of the world at < 1%. This considerable geographic variation in haplotype frequencies impacts the interpretation of CYP2C8/CYP2C9 association studies, and has pharmacogenomic implications for drug interactions. The Pharmacogenomics Journal (2009) 9, 283-290; doi: 10.1038/tpj.2009.10; published online 21 April 2009

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available